NF1, NF2, SMARCB1, SPRED1
- Legius Syndrome
- Neurofibromatosis Type 1
- Neurofibromatosis Type 2
- Establish or confirm a clinical diagnosis Identification of at-risk family members
- Development of an appropriate evaluation and management
- Deletion/Duplication Analysis
- Next-Gen Sequencing
81405x2, 81406x1, 81408x1
*The CPT codes provided are based on AMA guidelines and are for informational purposes only. CPT coding is the sole responsibility of the billing party. Please direct any questions regarding coding to the payer being billed.
**Turnaround times are estimates and begin once the sample(s) begin processing at the GeneDx lab and could be extended in situations outside GeneDx’s control.
Targeted Variant Testing